Pristiq (Desvenflazine), a serotonin-norepinephrine reuptake inhibitor (SNRI), is administered for the treatment of depression, anxiety, and panic disorders. It was developed and marketed by Wyeth, currently a division of pharmaceutical giant Pfizer. Pristiq works by preventing the reuptake of serotonin and norepinephrine, neurotransmitters that are imbalanced when a person is depressed.
Symptoms Associated with Pristiq Side Effects
Recently, Pristiq has been associated with a number of symptoms. Aside from minor side effects, which include nausea, dizziness, dry mouth, diarrhea, and increased sweating, severe Pristiq side effects include suicidal thoughts or behavior, increased anxiety, hostility or aggressiveness, engaging in unusual or dangerous activities, and restlessness.
Pristiq Linked to Birth Defects
When taken by a pregnant woman during the third trimester, Pristiq may cause fetal complications. Newborns are said to experience difficulty in breathing, seziures, lack of oxygen in the blood, feeding difficulties, tremors, and irritability. In addition, infants are also at risk for developing persistent pulmonary hypertension of the newborn (PPHN). PPHN is a condition where the arteries in the lungs of a newborn child remain constricted after delivery, limiting the amount of blood flow to the lungs and, therefore, the amount of oxygen in the blood stream. There are several key signs of this disease that should be noticed by doctors very soon after delivery. Among the symptoms of this condition are cyanosis (skin having bluish tinge), rapid heart rate, rapid breathing, and respiratory distress. The baby may experience difficulty in breathing, tremors and seizures.
Additional Pristiq Birth Defects
Some other known birth defects that are linked with the use of Pristiq by a woman during the first trimester of pregnancy include clubfoot, cleft lip, cleft palate, heart defects, lung defects, neural tube defects, and spina bifida. Despite reminders and warnings from the US Food and Drug Administration (FDA), the manufacturers of Pristiq maintain that there are no severe risks associated with taking Pristiq during pregnancy. Even with all the risks associated with Pristiq birth defects, the FDA still has not issued a Pristiq recall.
Pristiq has been given a “Pregnancy Category C” by the FDA, which is given to medications that have not been studied in pregnant humans but show side effects in animal studies.
Please Speak With Your Doctor Before Discontinuing Use of Pristiq or Any Other Prescription Medication.
Have You or a Loved One Given Birth to a Child with Birth Defects While On or Recently After Discontinuing Pristiq?
If you or a loved one have given birth to a child with birth defects while on or recently after discontinuing the antidepressant medication Pristiq, you may want to speak with a RI attorney regarding a potential Pristiq lawsuit. d’Oliveira & Associates, Rhode Island personal injury lawyers, are working with some of the leading lawyers in the country who are handling these cases.
Please contact the law offices of d’Oliveira & Associates at 1-800-992-6878 or fill out a contact form for a free legal consultation.